Clinical and Metabolic Determinants of Hepatic Fibrosis in Patients with Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD) – Insights from a Bangladeshi Cohort. The Insight [Internet]. 2025 Dec. 17 [cited 2026 May 10];8(03):588-92. Available from: https://bdjournals.org/insight/article/view/814